Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Notice to Debentureholders

RNS ANNOUNCEMENT Royal Bank of CanadaSeptember 28, 2023 Notice to Debentureholders ROYAL BANK OF CANADAU.S. $300,000,000 Floating Rate Debenture Notes Due 2085 (the "Notes")ISIN: GB0007542557 NOTICE IS HEREBY GIVEN that for the interest period commencing on September 30, 2023, the Notes will bear interest at the rate of 5.87500% per annum. The interest payable on December 29, 2023 against Coupon No. 151 will be USD14.850694 per USD1,000 nominal. On March 5, 2021, the U.K. Financial Conduct Authority (the "FCA") announced that USD LIBOR settings for all tenors of USD

Metso to deliver 16 cone crushers for Rio Tinto’s iron ore mines in Australia

Metso Corporation’s press release on September 28, 2023, at 09:00 a.m. EESTRio Tinto has awarded Metso an order for ten HP Series cone crushers to be installed at the Tom Price iron ore mine in Western Australia. This order follows the initial award of six HP series cone crushers in late 2022. The crushers in the initial order are currently being delivered to the Paraburdoo iron ore mine and the Pilbara mine. The latest order is booked in the Minerals segment’s third-quarter 2023 orders received. “The HP500™ cone crushers will replace the long-serving Symons cone crushers. The compact

AAX Biotech welcomes new CEO to drive advancements in next-generation antibody therapeutics

Biotech company AAX Biotech, specializing in innovative, patentable technologies for improving antibody-based medicines, is taking a significant step forward by appointing Maria Lisa Knudsen, PhD, as CEO. The appointment is expected to contribute to the company's growth and the development of its pioneering technologies.AAX Biotech is a Swedish startup biotech company aiming to solve unmet needs in developing next-generation antibody therapeutics. The company’s two unique and patentable technologies, Seqitope™ and Opti-mAb™, improve the performance and developability of antibody-based

Veidekke: expects lower production in construction markets

Veidekke anticipates a 13% drop in production in the Scandinavian construction markets by the end of 2024, while positive developments include high infrastructure-related activity and cost stabilisation. Although construction-cost inflation appears to be slowing and development trends are expected to normalise going forward, prices are currently expected to remain at their present high levels. Veidekke’s market update assumes production in the Scandinavian construction markets to drop 6% in 2023, and 7% in 2024. The three countries are at somewhat different cyclical stages. While

Lucara Diamond Corp. Announces Termination of Diamond Sales Agreement

VANCOUVER, BC, September 27, 2023 /CNW/ - (LUC – TSX, LUC – BSE, LUC – Nasdaq Stockholm)   Lucara Diamond Corp. (“Lucara” or the “Company”) announces the termination of the Diamond Sales Agreement between Lucara, Lucara Botswana (Proprietary) Limited and HB Trading BV (“HB”).  Lucara exercised its right to terminate the agreement following a material breach of financial commitments by HB. Lucara will continue to use its established mechanisms to sell Karowe’s rough diamond production, namely through its Clara diamond sales platform, traditional tenders and other value-added mechanisms

Interior Design Trends 2024

Are you considering upgrading or decorating your home? The year is very quickly coming to an end, and soon, we'll be moving right into 2024. With each new year comes new trends in all aspects of life, including in the interior design space. So, how do we know what interior design trends will be popular in 2024?   [A room with a fireplace and couches Description automatically generated]   Interior design expert Ryan McDonough at MyJobQuote.co.uk  has teamed up with a number of home and interior experts to create this list of the top interior design

Nordea Bank Abp: Repurchase of own shares on 27.09.2023

Nordea Bank AbpStock exchange release – Changes in company’s own shares27.09.2023 at 22.30 EET Nordea Bank Abp (LEI: 529900ODI3047E2LIV03) has on 27.09.2023 completed repurchases of own shares (ISIN: FI4000297767) as follows: +----------+-------+-------------------+-------------------+| Trading |Number | Weighted average |Total cost, EUR* **||venue (MIC| of |price / share, EUR*| || Code) |shares | ** | |+----------+-------+-------------------+-------------------+|XHEL |108,301|10.27 |1,112,522.

SmartCraft ASA (SMCRT) - Transactions carried out under the share buy-back program

Please see below information about transactions made under the share buy-back programme for SmartCraft ASA (“SmartCraft”) (Ticker: SMCRT NO). Date on which the share buy-back programme was announced: 28 April 2023. The duration of the buy-back programme: 28 April 2023 until no later than the day before the Issuer's Annual General Meeting in 2024. Size of the buy-back programme: Up to 3,430,446 shares, for a maximum consideration of NOK 85,000,000. From 19 September 2023 until 27 September 2023, SmartCraft has purchased a total of 34,509 own shares at an average price of NOK 20.

GF Piping Systems supplies products for CO\2\ removal

GF Piping Systems is contributing both technology and expertise to a number of carbon capture and removal projects. As part of this effort, the Swiss flow solutions provider has started a collaboration with neustark, a climate tech company specializing in removing CO\2\ from the atmosphere and permanently storing it in demolition concrete.To limit the increase in global average temperature to 1.5°C as set out by the IPCC (Intergovernmental Panel on Climate Change), it is necessary to reach net zero by 2050. Achieving net zero not only requires massive emissions reductions, but also the

Calliditas Therapeutics granted orphan drug designation by the FDA for the treatment of Alport syndrome with setanaxib

Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to the company for the treatment of Alport syndrome with setanaxib.Based on supportive pre-clinical work, Calliditas plans to initiate a randomized, placebo-controlled phase 2 clinical study in Alport syndrome with around 20 patients in the fourth quarter of 2023. “We are excited to start another clinical program in the renal space targeting an orphan indication where today there are no approved products,

Capsol Technologies: Minutes of Extraordinary General Meeting

Oslo, Norway, 27 September 2023An extraordinary general meeting of Capsol Technologies was held on Wednesday 27September 2023 at 14:00h CET.Please find attached the following document:• Minutes of Extraordinary General Meeting Capsol Technologies 27 Sept 2023For further information, please contact:Jan KiellandChief Executive Officer, Capsol Technologies+47 415 69 974jan.kielland@capsoltechnologies.comTone BekkestadChief Marketing Officer, Capsol Technologies+47 412 92 013tone.bekkestad@capsoltechnologies.comAbout Capsol TechnologiesCapsol Technologies is a

Hoist Finance has successfully issued bonds for a total amount of SEK 600 million

Hoist Finance AB (Baa3/neg outlook), ("Hoist Finance"), has successfully issued two senior unsecured bonds for a total amount of SEK 600m. · The first bond amounts to SEK 350 million and has a tenor of 3.0 years and a floating rate interest of STIBOR 3m + 500 bps · The second bond amounts to SEK 250 million, has a tenor of 3.0 years and a fixed rate interest of 8.843% The proceeds from the issued bonds will be used for general corporate purposes. The instruments will be listed on the regulated market of Irish Stock Exchange plc, known as Euronext Dublin. The bonds are expected to

Getinge reaches settlements with insurer Trygg-Hansa Försäkring and If Skadeförsäkringar

Getinge announces settlements with Trygg-Hansa Försäkring filial, Swedish branch of Tryg Forsikring A/S, and If Skadeförsäkringar AB (publ), related to insurance compensation for product liability claims regarding surgical mesh products. The settlement agreements were signed today and the settlement compensation amount in total to SEK 450 M.On November 16, 2020, Getinge AB (publ) and its subsidiaries Atrium Medical Corporation and Maquet Cardiovascular US Sales, LLC filed a lawsuit against the insurer Trygg-Hansa Försäkring filial (former Moderna Försäkringar), Swedish branch of Tryg

Sweden Island Gotland and Shailene Woodley Challenge the World to Share Ugly Lawns

Sweden’s biggest island Gotland is now exporting its successful water conservation initiative from last year globally. Together with the actor and environmental activist Shailene Woodley, Region Gotland is now launching the competition "The World's Ugliest Lawn". Photo Credit: Region Gotland. A number of entries in "Gotland's Ugliest Lawn” competition 2022.   Last year's competition, "Gotland's Ugliest Lawn," helped reduce household water consumption on Gotland by 5% compared to the previous summer.   Gotland is regularly experiencing drought and water scarcity. Saving

Transaction in Own Shares

FIDELITY JAPAN TRUST PLC TRANSACTION IN OWN SHARES The Board of Fidelity Japan Trust PLC ("the Company") announces that on 27 September 2023 the Company bought into Treasury 15,000 of its own shares at a price of 166.5000 pence per share.  The Company's issued ordinary share capital is 136,161,695 of which 7,565,136 shares are held in Treasury, which attract no voting rights. Therefore, the total number of voting rights in the Company is now 128,596,559. The above figure (128,596,559) may be used by shareholders as the denominator for the calculations by which they will

Photocure ASA: Change of Board Composition

Oslo, Norway, 28 September 2023: Photocure, The Bladder Cancer Company, announces changes to the composition of its Board of Directors. Reference is made to the stock exchange notice on 9 August 2023 and that Jan H. Egberts, M.D. has decided to step down from his position as Chairperson of the Company's Board of Directors. Dr. Egberts has now resigned from the Board of Directors of Photocure ASA.The current board members of Photocure will constitute the Board of Directors after Dr. Egberts’ resignation until the general meeting elects a new Board of Directors. Further, the members of the

KEF3 recognises Staffordshire University's impact on growth

The significant impact Staffordshire University is having on supporting graduate start-up companies and upskilling the region’s workforce has been recognised in a new report. The Knowledge Exchange Framework  (KEF) examines the performance of higher education providers and how they engage with society and the economy. It also shows that Staffordshire University is having a greater impact on local growth and regeneration – a result of the University’s work to support SMEs to develop new products and services and provide short courses to develop and upskill the

Transaction in Own Shares

FIDELITY CHINA SPECIAL SITUATIONS PLC TRANSACTION IN OWN SHARES The Board of Fidelity China Special Situations Plc ("the Company") announces that on 27 September 2023 the Company bought 250,000 of its own shares for cancellation at a price of 211.290 pence per share.  The Company's issued ordinary share capital is 562,653,839 shares of which 85,629,548 shares are held in Treasury, which attract no voting rights. Therefore, the total number of voting rights in the Company is 477,024,291. The above figure (477,024,291) may be used by shareholders as the denominator for the

SBB announces a new date for the third quarter interim report

Due to the new decentralised group structure that was presented on September 24, 2023, SBB has decided on a new publication date for the quarterly report for the third quarter of 2023. The company’s aim is that the new group structure should improve financial reporting and transparency. Therefore, SBB has decided on a new publication date to give the company sufficient time to complete the report according to the new structure. The new publication date for the quarterly report for the third quarter 2023 is 9 November 2023 at 08:00 CET. The previously communicated date for publication

Redsense Medical arranged Congressional Briefing to address Venous Needle Dislodgement

The briefing was held on September 27, 2023 in the Rayburn House Office Building, Washington DC with the purpose to bring together various stakeholders in the renal area to share knowledge, experience and discuss risks with Venous Needle Dislodgement (VND) and how to increase patient safety for hemodialysis patients. In addition to Redsense, The American Association of Kidney Patients (AAKP) and Emergency Care Research Institute (ECRI) presented during the briefing. AAKP is the oldest and largest independent kidney patient organization and in the United States and ECRI is a global

Bittium Corporation: SHARE REPURCHASE 27.9.2023

Bittium Corporation  ANNOUNCEMENT  27.9.2023 Bittium Corporation: SHARE REPURCHASE 27.9.2023 In the Helsinki Stock Exchange Trade date           27.9.2023Bourse trade         BuyShare                  BITTIAmount             2 616 SharesAverage price/ share    3,7450 EURTotal cost            9 796,92 EUR Bittium Corporation now holds a total of 206 323 sharesincluding the shares repurchased on 27.9.2023 On behalf of Bittium Corporation Nordea Bank Oyj

ExpreS2ion announces changes to leadership team

Hørsholm, Denmark, 27 September 2023 - ExpreS2ion Biotech Holding AB (“ExpreS2ion” or the “Company”), a pioneer in the development of innovative vaccines for a healthier world, today announced that Dr. Mattis Ranthe, Chief Medical Officer, and Dr. Mette Thorn, Senior Vice President of Preclinical Development, are stepping down from their positions in the Company following the future strategic focus on ExpreS2ion’s exploratory vaccine pipeline and technology platforms, as announced in press release of 17 August 2023. Dr. Ranthe will continue supporting the Company through the end of 2023 to

Cereno Scientific releases Insights video season 2 episode 3 with Phil B. Adamson, Abbott

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that episode 3 of season 2 in the Insights Video Series is released. The video highlights the cutting-edge technology CardioMEMS HR System used in the Phase II study of CS1 through a collaboration agreement with Abbott. Participating in the video is Phil B. Adamson, MD, MSc Divisional Vice President and Chief Medical Officer of the Heart Failure Division, Abbott, and collaborative partner in the Phase II study of CS1.Watch here: Insights

There are no items matching the current filter
There are no more items matching the current filter
Back to top